Literature DB >> 25854794

Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain.

T Mainka1,2, N M Malewicz1, R Baron3, E K Enax-Krumova4, R-D Treede5, C Maier1.   

Abstract

BACKGROUND: Topical high-dose capsaicin acting on TRPV1 receptors and inducing an intraepidermal decrease in the small nerve fibre count is effective in treating neuropathic pain (NP). Sensory changes after capsaicin application, their correlation with pain relief and their role as possible predictors of response have been insufficiently analysed. We hypothesized a positive correlation between pain relief and increase in the warmth detection threshold (WDT), indicating loss of C-fibre function, and higher response rates in patients with preserved C-fibre function or heat hyperalgesia before application.
METHODS: Quantitative Sensory Testing (DFNS protocol) was conducted in 20 unilaterally treated patients with peripheral NP (peripheral nerve injury: n = 14, polyneuropathy: n = 4, postherpetic neuralgia: n = 2) before and 2, 4, 6 and 8 weeks after application of capsaicin (8%) in this open-label study. Response was defined as ≥30% or ≥2 (Numeric Rating Scale: 0-10) decrease of current pain at any follow-up compared to baseline.
RESULTS: In all patients, WDT significantly increased 8 weeks after capsaicin application, but did not correlate with pain relief in responders (n = 10, r = 0.179, p = 0.141). Before treatment, responders showed significantly higher z-values for the cold (CPT, +0.7 ± 1.1 vs. -0.4 ± 0.9) and mechanical pain threshold (MPT; 0.7 ± 2.5 vs. -1.2 ± 1.3), but did not differ from non-responders regarding WDT or heat pain threshold. A sum of the z-values for CPT and MPT >0.8 before treatment identified responders with 100% specificity and 70% sensitivity.
CONCLUSIONS: Efficacy of capsaicin does not correlate with the induced loss of function of small fibres, measured by QST. Presence of cold and pinprick hyperalgesia seems to be predictive of response to capsaicin (8%).
© 2015 European Pain Federation - EFIC®

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25854794     DOI: 10.1002/ejp.703

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  30 in total

Review 1.  Neurology--the next 10 years.

Authors:  Ralf Baron; Donna M Ferriero; Giovanni B Frisoni; Chetan Bettegowda; Ziya L Gokaslan; John A Kessler; Annamaria Vezzani; Stephen G Waxman; Sven Jarius; Brigitte Wildemann; Michael Weller
Journal:  Nat Rev Neurol       Date:  2015-10-27       Impact factor: 42.937

2.  [Botulinum toxin A injections in neuropathic pain : A post-hoc subgroup analysis of patients with peripheral nerve injury].

Authors:  L Eitner; J Vollert; C Maier; N Attal
Journal:  Schmerz       Date:  2017-10       Impact factor: 1.107

3.  The time course of brief and prolonged topical 8% capsaicin-induced desensitization in healthy volunteers evaluated by quantitative sensory testing and vasomotor imaging.

Authors:  Silvia Lo Vecchio; Hjalte Holm Andersen; Lars Arendt-Nielsen
Journal:  Exp Brain Res       Date:  2018-05-29       Impact factor: 1.972

Review 4.  Assessment of Chronic Pain: Domains, Methods, and Mechanisms.

Authors:  Roger B Fillingim; John D Loeser; Ralf Baron; Robert R Edwards
Journal:  J Pain       Date:  2016-09       Impact factor: 5.820

5.  Usefulness of laser-evoked potentials and quantitative sensory testing in the diagnosis of neuropathic spinal cord injury pain: a multiple case study.

Authors:  G Landmann; M F Berger; L Stockinger; E Opsommer
Journal:  Spinal Cord       Date:  2017-01-24       Impact factor: 2.772

6.  Sensory defunctionalization induced by 8% topical capsaicin treatment in a model of ultraviolet-B-induced cutaneous hyperalgesia.

Authors:  Silvia Lo Vecchio; Hjalte Holm Andersen; Jesper Elberling; Lars Arendt-Nielsen
Journal:  Exp Brain Res       Date:  2021-07-24       Impact factor: 1.972

Review 7.  [Neuropathic pain. How to open the blackbox].

Authors:  C Maier; R Baron; C Sommer
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

Review 8.  Sensory profiling in animal models of neuropathic pain: a call for back-translation.

Authors:  Andrew S C Rice; Nanna B Finnerup; Harriet I Kemp; Gillian L Currie; Ralf Baron
Journal:  Pain       Date:  2018-05       Impact factor: 6.961

Review 9.  The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.

Authors:  Shannon M Smith; Robert H Dworkin; Dennis C Turk; Ralf Baron; Michael Polydefkis; Irene Tracey; David Borsook; Robert R Edwards; Richard E Harris; Tor D Wager; Lars Arendt-Nielsen; Laurie B Burke; Daniel B Carr; Amy Chappell; John T Farrar; Roy Freeman; Ian Gilron; Veeraindar Goli; Juergen Haeussler; Troels Jensen; Nathaniel P Katz; Jeffrey Kent; Ernest A Kopecky; David A Lee; William Maixner; John D Markman; Justin C McArthur; Michael P McDermott; Lav Parvathenani; Srinivasa N Raja; Bob A Rappaport; Andrew S C Rice; Michael C Rowbotham; Jeffrey K Tobias; Ajay D Wasan; James Witter
Journal:  J Pain       Date:  2017-02-27       Impact factor: 5.820

Review 10.  Fight fire with fire: Neurobiology of capsaicin-induced analgesia for chronic pain.

Authors:  Vipin Arora; James N Campbell; Man-Kyo Chung
Journal:  Pharmacol Ther       Date:  2020-11-10       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.